Hollander: 'Truly, it’s hard to make the case that this vaccine for this cohort makes sense even for a higher risk infant until/unless we had more safety and efficacy data. For a healthy infant, or the majority of infants in the U.S. who have already had Covid? Given annual hospitalization rates probably in the 1 in many 1000s for this group, it seems very unlikely that benefits outweigh risks for this particular vaccine.
'I know the FDA, CDC and the White House have enthusiastically endorsed the Moderna Covid-19 vaccine for all infants. I think a system that is capable of such an endorsement is broken, and in dire need of fixing.'
Comments